Skip to content

Arthrogryposis Multiplex Congenita in Pediatric Age: Correlation Between MUScular MRI and Functional Evaluation

Arthrogryposis Multiplex Congenita in Pediatric Age: Correlation Between MUScular MRI and Functional Evaluation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05393375
Acronym
AMUSE
Enrollment
97
Registered
2022-05-26
Start date
2022-05-01
Completion date
2022-11-01
Last updated
2023-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AMC-Arthrogryposis Multiplex Congenita, Arthrogryposis Multiplex Congenita, Pediatric ALL

Keywords

Arthrogryposis Multiplex Congenita, Pediatric, Mercuri Score, MRI, Fibro-adipous infiltration, Functional capacity, Rehabilitation, Retrospective observational study

Brief summary

The aim of our study is to evaluate the correlation between quantified fibro-adipous infiltration of muscles on MRI assessed by MERCURI Score and the functional abilities (deficiencies, activity limitations and social participation of pediatric patients with arthrogryposis.

Detailed description

Arthrogryposis multiplex congenita (AMC) is a group of rare diseases characterized by joint contractures at two or more distinct joint levels at birth. More than 400 causes are currently known. The prevalence is estimated at 1/3000 to 1/2000. Joint limitations are not progressive, but the functional consequences have a lifelong impact on patients. Correlations between fibro-adipous infiltration and muscular deficits have already been studied in other neuromuscular diseases such as Pompe disease or Duchenne muscular dystrophy. These studies concluded on a good correlation between disease progression and severity, muscle strength, and fatty infiltration assessed by Mercuri score. The investigators concluded that muscular MRI can be used as a non-invasive biomarker and a tool to follow the progression of neuromuscular disease and help evaluate the potential effects of therapies. The aim of this project is to define whether MRI could also be used as a tool, through the assessment of muscle fatty infiltration, to help predict the functional abilities of our patients with AMC, and more specifically the two most frequent types, Amyoplasia and distal arthrogryposis. The investigators will analyze fatty infiltration measured by muscle MRI and quantify it using the MERCURI score which was developed by Mercuri et al. (Mercuri et al. 2002) as a semi-quantitative score to quantify fibro-adipose muscle infiltration on muscle MRI. The investigators will evaluate musculoskeletal deficiencies and limitations of activity from data obtained from patients followed in our AMC reference center at the University Hospital Grenoble Alpes (CHUGA). The investigators will include data from 220 children, 97 of whom have had a complete check-up including a muscle MRI. The investigators will study the existence of a correlation between this score and the deficiencies and limitations of activity. The investigators will then evaluate the potential predictive role of fatty infiltration measured on MRI in the functional abilities of the patients. This characterization will help to better determine and anticipate the functional capacities of our patients from the beginning of their treatment to improve their functional prognosis. This initial work could enhance the reflection on the biomechanical modeling of joints and key functions such as standing and the acquisition of walking, in order to pave the way for rehabilitation and compensation methods that are better adapted to patient's needs.

Interventions

OTHERNo intervention

No intervention

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
0 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* age \< 18 at the first clinical evaluation or follow up exclusively in CHUGA pediatric rehabilitation unit * Clinical or molecular diagnosis of AMC established by geneticists at CHUGA * functional evaluation during consultation and follow-up in CHUGA pediatric rehabilitation unit * Muscle MRI of upper limbs, lower limbs and trunk performed at CHUGA pediatric radiology unit

Exclusion criteria

* Contra indication MRI. * MRI non exploitable. * Patient under guardianship or deprived of liberty

Design outcomes

Primary

MeasureTime frameDescription
Mercuri Scores of upper limbs, trunk, and lower limbs evaluated on muscle MRI T1through study completion, an average of 1 yearThe degree of fatty muscle infiltration was assessed on muscular MRI and quantified by Mercuri score, each muscle was staged as follows: 1\. Normal appearance, 2. Mild involvement (30-60% fatty infiltration). 3. Moderate involvement (\>60% fatty infiltration). 4. Severe involvement (complete infiltration). The degree of muscle fat infiltration was assessed with at least 2 visible slices, and performed by two independent operators. In case of divergent assessments, a consensus was reached after discussion.

Secondary

MeasureTime frameDescription
Passive range of motion (PROM)through study completion, an average of 1 yearEvaluated by physiotherapists; the range of motion of each movement in degrees was normalized with respect to the normal maximal movement, expressed as percentages
Reaching scorethrough study completion, an average of 1 yearReaching capacity was assessed by ad hoc test. Patients were instructed to successively touch some body targets with upper limbs : mouth, head, forehead, neck, back, stomach, gluteal region, opposite shoulders, ipsilateral shoulders, knee, feet, Beggar's pose, position of the oath, and Zenith Pose. Each gesture was marked yes if successful or no if not. Responses were transformed into a binary variable with yes being worth 1 and no being worth 0 to allow for statistical correlations afterwards. The total score was calculated on both sides averaged and ranged from 0 to 14 points
Ambulatory statusthrough study completion, an average of 1 yearAmbulatory statuses were gathered by the teams during the check-ups as well as the age of acquisition of walking if available and the use or not of technical aids
Muscular weaknessthrough study completion, an average of 1 yearMuscular weakness assessed by function (flexion, extension etc.) and not by each muscle, using the Medical Research Council (MRC) scale (from 0 to 5). The quotation was as follows: 0, no contraction; 1, flicker or trace of contraction; 2, active movement possible only with gravity eliminated; 3, active movement against gravity in the whole range of motion; 4, active movement against gravity and resistance; 5, quasi-normal strength) Evaluated by physiotherapists, occupational therapists and physician during evaluation.
Activity limitationthrough study completion, an average of 1 yearGathered evaluating living habits and essential acts of daily life such as element of the Functional Independence Measure (FIM) : feeding, dressing, potty training, toileting, schooling, transfers, locomotion, and also existence of leisure, hobby, presence of human or technical helps.
Surgery Historythrough study completion, an average of 1 yearSurgical history for each patient
Human and technical Helpthrough study completion, an average of 1 yearuse of a technical aid (manual or electric wheelchair ...), or humain for daily life activities
School statusthrough study completion, an average of 1 yearType of schooling (mainstream education, adapted schooling, presence of a carer)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026